Patient’s diagnosis and dose-level assignment
Tumor diagnosis . | No. of patients at dose level (mg) . | All patients . | |||||
---|---|---|---|---|---|---|---|
25 . | 75 . | 100 . | 125 . | 150 . | No. . | % . | |
AML | 0 | 0 | 0 | 9 | 0 | 9 | 12.3 |
ALL | 0 | 0 | 0 | 1 | 0 | 1 | 1.4 |
CLL | 1 | 2 | 1 | 2 | 1 | 7 | 9.6 |
HD | 1 | 0 | 2 | 4 | 1 | 8 | 11 |
NHL | 0 | 0 | 3 | 7 | 3 | 13 | 17.8 |
LCH | 0 | 0 | 0 | 0 | 1 | 1 | 1.4 |
MM | 0 | 0 | 2 | 32 | 0 | 34 | 46.6 |
Tumor diagnosis . | No. of patients at dose level (mg) . | All patients . | |||||
---|---|---|---|---|---|---|---|
25 . | 75 . | 100 . | 125 . | 150 . | No. . | % . | |
AML | 0 | 0 | 0 | 9 | 0 | 9 | 12.3 |
ALL | 0 | 0 | 0 | 1 | 0 | 1 | 1.4 |
CLL | 1 | 2 | 1 | 2 | 1 | 7 | 9.6 |
HD | 1 | 0 | 2 | 4 | 1 | 8 | 11 |
NHL | 0 | 0 | 3 | 7 | 3 | 13 | 17.8 |
LCH | 0 | 0 | 0 | 0 | 1 | 1 | 1.4 |
MM | 0 | 0 | 2 | 32 | 0 | 34 | 46.6 |